Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Profile: a native son comes home to help.

J Cohen

    Science (New York, N.Y.)
    |July 15, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Researchers are developing an AIDS vaccine using a local Kenyan HIV strain. This work builds on Dr. Omu Anzala's expertise in HIV immunology, aiming for a targeted vaccine strategy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AIDS vaccines: is older better?

    Science (New York, N.Y.)·1992
    Same author

    AIDS vaccines. Trials set in high-risk populations.

    Science (New York, N.Y.)·1992
    Same author

    Dingell rips Healy for 'obstructionism'.

    Science (New York, N.Y.)·1992
    Same author

    Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release.

    Lancet (London, England)·1992
    Same author

    Pediatric AIDS vaccine trials set.

    Science (New York, N.Y.)·1992
    Same author

    A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.

    The Journal of antimicrobial chemotherapy·1992

    Area of Science:

    • Immunology
    • Vaccinology
    • Virology

    Background:

    • Dr. Omu Anzala returned to Kenya in 1996 after Ph.D. research on human immunodeficiency virus (HIV) and the immune system.
    • He joined a collaborative AIDS research project involving his university and the University of Manitoba.

    Discussion:

    • The International AIDS Vaccine Initiative (IAVI) is funding this project.
    • The goal is to develop an AIDS vaccine tailored to a specific HIV strain prevalent in Kenya.

    Key Insights:

    • Focus on a Kenyan HIV strain for vaccine development.
    • Leveraging existing expertise in HIV immunology.

    Outlook:

    • Potential for a region-specific, effective AIDS vaccine.
    • Continued international collaboration in AIDS research.